These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

807 related items for PubMed ID: 24054178

  • 21. HFE based re-evaluation of heterozygous hemochromatosis.
    Moirand R, Guyader D, Mendler MH, Jouanolle AM, Le Gall JY, David V, Brissot P, Deugnier Y.
    Am J Med Genet; 2002 Sep 01; 111(4):356-61. PubMed ID: 12210292
    [Abstract] [Full Text] [Related]

  • 22. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience.
    De Gobbi M, D'Antico S, Castagno F, Testa D, Merlini R, Bondi A, Camaschella C.
    Haematologica; 2004 Oct 01; 89(10):1161-7. PubMed ID: 15477198
    [Abstract] [Full Text] [Related]

  • 23. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leiendecker-Foster C, Speechley M, Snively BM, Holup JL, Thomson E, Sholinsky P, Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators.
    N Engl J Med; 2005 Apr 28; 352(17):1769-78. PubMed ID: 15858186
    [Abstract] [Full Text] [Related]

  • 24. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
    Barton JC, Acton RT, Leiendecker-Foster C, Lovato L, Adams PC, McLaren GD, Eckfeldt JH, McLaren CE, Reboussin DM, Gordeuk VR, Speechley MR, Reiss JA, Press RD, Dawkins FW, Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators.
    Genet Test; 2007 Apr 28; 11(3):269-75. PubMed ID: 17949288
    [Abstract] [Full Text] [Related]

  • 25. Examining the clinical use of hemochromatosis genetic testing.
    Lanktree MB, Lanktree BB, Paré G, Waye JS, Sadikovic B, Crowther MA.
    Can J Gastroenterol Hepatol; 2015 Apr 28; 29(1):41-5. PubMed ID: 25706573
    [Abstract] [Full Text] [Related]

  • 26. Diagnosis and treatment of hereditary hemochromatosis: an update.
    Kanwar P, Kowdley KV.
    Expert Rev Gastroenterol Hepatol; 2013 Aug 28; 7(6):517-30. PubMed ID: 23985001
    [Abstract] [Full Text] [Related]

  • 27. Hereditary hemochromatosis: implications for South Dakota physicians.
    Stampe C, Weiland K.
    S D Med; 2013 Jan 28; 66(1):15, 17-8. PubMed ID: 23342715
    [Abstract] [Full Text] [Related]

  • 28. Iron overload in HFE C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants.
    Aguilar-Martinez P, Grandchamp B, Cunat S, Cadet E, Blanc F, Nourrit M, Lassoued K, Schved JF, Rochette J.
    Haematologica; 2011 Apr 28; 96(4):507-14. PubMed ID: 21228038
    [Abstract] [Full Text] [Related]

  • 29. [Hereditary hemochromatosis HFE: regulatory and economic aspects of diagnosis and medical management].
    Ropert-Bouchet M, Fajardy I, Michel H.
    Ann Biol Clin (Paris); 2012 Apr 28; 70(4):405-11. PubMed ID: 22796612
    [Abstract] [Full Text] [Related]

  • 30. [Hereditary hemochromatosis].
    Dantas W.
    Rev Gastroenterol Peru; 2001 Apr 28; 21(1):42-55. PubMed ID: 12170286
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Iron overload and prolonged ingestion of iron supplements: clinical features and mutation analysis of hemochromatosis-associated genes in four cases.
    Barton JC, Lee PL, West C, Bottomley SS.
    Am J Hematol; 2006 Oct 28; 81(10):760-7. PubMed ID: 16838333
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Metals and the liver.
    Maxwell KL, Kowdley KV.
    Curr Opin Gastroenterol; 2012 May 28; 28(3):217-22. PubMed ID: 22395570
    [Abstract] [Full Text] [Related]

  • 35. HFE genotyping in patients with elevated serum iron indices and liver diseases.
    Evangelista AS, Nakhle MC, de Araújo TF, Abrantes-Lemos CP, Deguti MM, Carrilho FJ, Cançado EL.
    Biomed Res Int; 2015 May 28; 2015():164671. PubMed ID: 25654085
    [Abstract] [Full Text] [Related]

  • 36. Prevalence of C282Y, H63D, and S65C mutations in hereditary HFE-hemochromatosis gene in Lithuanian population.
    Kucinskas L, Juzenas S, Sventoraityte J, Cedaviciute R, Vitkauskiene A, Kalibatas V, Kondrackiene J, Kupcinskas L.
    Ann Hematol; 2012 Apr 28; 91(4):491-5. PubMed ID: 21947086
    [Abstract] [Full Text] [Related]

  • 37. Validation of an unlabeled probe melting analysis assay combined with high-throughput extractions for genotyping of the most common variants in HFE-associated hereditary hemochromatosis, C282Y, H63D, and S65C.
    Sumner K, Hubley L, Pont-Kingdon G, Mitchell S, Wayman T, Wilson A, Meadows C, Elenitoba-Johnson K, Pattison D, Dobrowolski S, Best H, Lyon E.
    Genet Test Mol Biomarkers; 2012 Jul 28; 16(7):656-60. PubMed ID: 22364140
    [Abstract] [Full Text] [Related]

  • 38. Prevalence of H63D, S65C, and C282Y hereditary hemochromatosis gene variants in Madeira Island (Portugal).
    Spínola C, Brehm A, Spínola H.
    Ann Hematol; 2011 Jan 28; 90(1):29-32. PubMed ID: 20714725
    [Abstract] [Full Text] [Related]

  • 39. Recognition and management of hereditary hemochromatosis.
    Brandhagen DJ, Fairbanks VF, Baldus W.
    Am Fam Physician; 2002 Mar 01; 65(5):853-60. PubMed ID: 11898957
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.